Zdrowie i gospodarka · 06/04/2023
FDA Announces Draft Guidance for Patient-Focused Drug Development
The FDA has released a draft guidance document outlining how patient experience data can be used in regulatory decision-making for medical product development, as part of its Patient-Focused Drug Development initiative.
Source: Federal Register — Food and Drug AdministrationOpen original release →